The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trial

RECOMMENDED

HypertensionLipid-Lowering DrugsThrombosis and Stroke

Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial

Lancet.

Gupta A, Mackay J, Whitehouse A, Godec T, Collier T, Pocock S, Poulter N, Sever P

doi: 10.1016/S0140-

HypertensionThrombosis and Stroke

Blood pressure and in-hospital outcomes in patients presenting with ischaemic stroke

Eur Heart J.

Bangalore S, Schwamm L, Smith EE, Hellkamps AS, Suter RE, Xian Y, Schulte PJ, Fonarow GC, Bhatt DL

Cardiovascular Risk and Diseases

Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial)

Hypertension.

Khan NA, Rabkin SW, Zhao Y, McAlister FA, Park JE, Guan M, Chan S, Humphries KH

doi: 10.1161/

COMMENTED

Hypertension

Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)

★ 3 Recommended and commented by Prof. Dr Isabella Sudano, Faculty Member

JAMA Cardiol.

Vaduganathan M, Claggett BL, Juraschek SP, Solomon SD

doi: 10.1001/jamacardio.2019.6192.

RECOMMENDED

Heart Failure

Systolic Blood Pressure and Outcome in Patients Admitted With Acute Heart Failure: An Analysis of Individual Patient Data From 4 Randomized Clinical Trials

★ 2 Recommended by Prof. Dr Isabella Sudano, Faculty Member

J Am Heart Assoc

Grand J, Miger K, Sajadieh A, Køber L, Torp-Pedersen C, Ertl G, López-Sendón J, Pietro Maggioni A, Teerlink JR, Sato N, Gimpelewicz C, Metra M, Holbro T, Nielsen OW

doi: 10.1161/JAHA.121.022288

Atrial Fibrillation

Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial

Eur Heart J.

Böhm M, Brueckmann M, Eikelboom JW, Ezekowitz M, Fräßdorf M, Hijazi Z, Hohnloser SH, Mahfoud F, Schmieder RE, Schumacher H, Wallentin L, Yusuf S

doi: 10.1093/eurheartj/ehaa247.

Cardiovascular Risk and DiseasesHypertension

Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients with Hypertension: The Systolic Blood Pressure Intervention (SPRINT) Trial

Circulation.

Soliman EZ, Ambrosius WT, Cushman WC, Zhang ZM, Bates JT, Neyra JA, Carson TY, Tamariz L, Ghazi L, Cho ME, Shapiro BP, He J, Fine LJ, Lewis CE; SPRINT Research Study Group

doi: 10.1161/

Cardiovascular Risk and Diseases

Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials

Lancet.

Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JF, Mancia G, Redon J, Schmieder RE, Sliwa K, Weber MA, Williams B, Yusuf S

doi: 10.1016/S0140-6736

Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial.

Clin Cardiol.

Hagström E, Roe MT, Hafley G, Neely ML, Sidhu MS, Winters KJ, Prabhakaran D, White HD, Armstrong PW, Fox KA, Magnus Ohman E, Boden WE; TRILOGY ACS Investigators

doi: 10.1002/clc.22533.

Related content